With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.
The first Valsartan bellwether trial will begin on September 8, 2025, involving allegations that the generic hypertension drug contained toxic chemicals that resulted in a liver cancer diagnosis.
The judge presiding over all federal Bard PowerPort lawsuits will meet with lawyers today to review the status of pretrial proceedings and the selection of the next round of bellwether cases.
